Interpretation of the 2022 edition guidelines for hepatolenticular degeneration diagnosis and treatment.
10.3760/cma.j.cn501113-20220211-00065
- Author:
Wei HOU
1
;
Su Jun ZHENG
1
;
Zhong Ping DUAN
2
Author Information
1. The First Department of the Liver Disease Center, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
2. The Fourth Department of the Liver Disease Center, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
- Publication Type:Journal Article
- MeSH:
Gastroenterology;
Hepatolenticular Degeneration/therapy*;
Humans
- From:
Chinese Journal of Hepatology
2022;30(3):276-278
- CountryChina
- Language:Chinese
-
Abstract:
In order to help liver disease-related clinicians make rational decisions, the Inherited and Metabolic Liver Disease Cooperative Group of Hepatology Branch of Chinese Medical Association released the 2022 edition guidelines for hepatolenticular degeneration diagnosis and treatment. This article introduces the ten highlights of this guideline from the aspects of epidemiology, pathogenesis, clinical characteristics, laboratory tests, diagnosis, treatment, monitoring, and so forth, with practicality and operability as prominent features.
